AIDS in Latin America.
The epidemic in Latin America has placed an unexpected additional burden on the health care systems and national economies, already weak and affected by severe problems. Specific regional diseases in addition to common opportunistic infections, and particularly the high incidence of TB, produce a different picture compared with the United States and Europe. Access to ARV therapy is far from being universal in Latin America; nevertheless, some countries are providing HAART to all eligible patients, showing that it is not impossible to improve quality of care for people living with HIV infection in the region. Before assuming as definitive and irreversible that at least one or two generations will be sacrificed on the altar of inequity of our uneven world, we as acting scientists should join the struggle of millions of human beings claiming their right to be treated with the best drugs that science can offer today.
Cahn
P
P
Department of Infectious Diseases, University of Buenos Aires School of Medicine, Argentina.
Belloso
W H
WH
Murillo
J
J
Prada-Trujillo
G
G
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D019380:Anti-HIV Agents / Q000627:therapeutic use; D014355:Chagas Disease / Q000150:complications / Q000453:epidemiology; D006660:Histoplasmosis / Q000150:complications / Q000453:epidemiology; D006801:Humans; D007843:Latin America / Q000453:epidemiology; D007896:Leishmaniasis / Q000150:complications / Q000453:epidemiology; D016919:Meningitis, Cryptococcal / Q000150:complications / Q000453:epidemiology; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000453:epidemiology; D014390:Tuberculosis, Meningeal / Q000150:complications / Q000453:epidemiology
D019380:Anti-HIV Agents